Literature DB >> 17018746

Chemoresistance in solid tumours.

T R Wilson1, D B Longley, P G Johnston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018746     DOI: 10.1093/annonc/mdl280

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  57 in total

1.  Doxorubicin resistance mediated by cytoplasmic macrophage colony-stimulating factor is associated with switch from apoptosis to autophagic cell death in MCF-7 breast cancer cells.

Authors:  Mengxia Zhang; Hailiang Zhang; Fan Tang; Yuhua Wang; Zhongcheng Mo; Xiaoyong Lei; Shengsong Tang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-24

2.  Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells.

Authors:  Pornsiri Pitchakarn; Sonthaya Umsumarng; Sariya Mapoung; Pisamai Ting; Piya Temviriyanukul; Wanisa Punfa; Wilart Pompimon; Pornngarm Limtrakul
Journal:  J Nat Med       Date:  2017-06-21       Impact factor: 2.343

3.  Can the chemotherapeutic agents perform anticancer activity through miRNA expression regulation? Proposing a new hypothesis [corrected].

Authors:  Chiranjib Chakraborty; C George Priya Doss; Renu Sarin; Minna J Hsu; Govindasamy Agoramoorthy
Journal:  Protoplasma       Date:  2015-02-20       Impact factor: 3.356

Review 4.  Role of microRNAs in breast cancer.

Authors:  Ramesh Singh; Yin-Yuan Mo
Journal:  Cancer Biol Ther       Date:  2013-01-04       Impact factor: 4.742

5.  Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer.

Authors:  Maria J Fernández-Cabezudo; Issam Faour; Kenneth Jones; Devin P Champagne; Mohammed A Jaloudi; Yassir A Mohamed; Ghada Bashir; Saeeda Almarzooqi; Alia Albawardi; M Jawad Hashim; Thomas S Roberts; Haytham El-Salhat; Hakam El-Taji; Adnan Kassis; Dylan E O'Sullivan; Brock C Christensen; James DeGregori; Basel K Al-Ramadi; Mercedes Rincon
Journal:  JCI Insight       Date:  2016-05-19

6.  Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.

Authors:  Marta Geretto; Alessandra Pulliero; Camillo Rosano; Dinara Zhabayeva; Rakhmet Bersimbaev; Alberto Izzotti
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

7.  Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-κB signalling pathway and inducing apoptosis.

Authors:  Lili Liu; Dan Wang; Ying Qiu; Hongyan Dong; Xuemei Zhan
Journal:  Exp Ther Med       Date:  2017-12-22       Impact factor: 2.447

8.  Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells.

Authors:  Yunfei Zhou; Federico Tozzi; Jinyu Chen; Fan Fan; Ling Xia; Jinrong Wang; Guang Gao; Aijun Zhang; Xuefeng Xia; Heather Brasher; William Widger; Lee M Ellis; Zhang Weihua
Journal:  Cancer Res       Date:  2011-11-14       Impact factor: 12.701

9.  Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB.

Authors:  Nadine Rohwer; Christof Dame; Anja Haugstetter; Bertram Wiedenmann; Katharina Detjen; Clemens A Schmitt; Thorsten Cramer
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

10.  Orexin 2 receptor as a potential target for immunotoxin and antibody-drug conjugate cancer therapy.

Authors:  Masato Kishida; Kazunori Ishige; Tomohisa Horibe; Noriko Tada; Nobutaka Koibuchi; Junichi Shoda; Kiyoshi Kita; Koji Kawakami
Journal:  Oncol Lett       Date:  2011-12-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.